Exponentially weighted moving average chart as a suitable tool for nuchal translucency quality review

This study aimed to design an exponentially weighted moving average (EWMA) chart for the quality review of nuchal translucency (NT) and to assess its performance compared with the methods currently in use: retrospective distribution‐based methods and the cumulative sum (CUSUM) chart.

[1]  R Porcher,et al.  CUSUM: a tool for ongoing assessment of performance , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  Stefan H. Steiner,et al.  Detecting the start of an influenza outbreak using exponentially weighted moving average charts , 2010, BMC Medical Informatics Decis. Mak..

[3]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[4]  Karen A. F. Copeland.  Cumulative Sum Charts and Charting for Quality Improvement , 1999 .

[5]  Lionel Dessolle,et al.  How soon can I be proficient in embryo transfer? Lessons from the cumulative summation test for learning curve (LC-CUSUM). , 2009, Human reproduction.

[6]  Marcus B. Perry,et al.  The Exponentially Weighted Moving Average , 2010 .

[7]  K. Nicolaides,et al.  Delta‐NT or NT MoM: which is the most appropriate method for calculating accurate patient‐specific risks for trisomy 21 in the first trimester? , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[8]  James M. Lucas,et al.  Exponentially weighted moving average control schemes: Properties and enhancements , 1990 .

[9]  K. Nicolaides,et al.  Letter. Correct estimation of parameters for ultrasound nuchal translucency screening , 1998, Prenatal diagnosis.

[10]  Y. Ville.  Semi‐automated measurement of nuchal translucency thickness: blasphemy or oblation to quality? , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[11]  R Porcher,et al.  Quantitative and individualized assessment of the learning curve using LC‐CUSUM , 2008, The British journal of surgery.

[12]  F. Malone,et al.  Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[13]  E. S. Page.  CONTINUOUS INSPECTION SCHEMES , 1954 .

[14]  Mark Jones,et al.  Risk‐adjusted survival time monitoring with an updating exponentially weighted moving average (EWMA) control chart , 2009, Statistics in medicine.

[15]  I. Staboulidou,et al.  A mixture model of nuchal translucency thickness in screening for chromosomal defects: validation of a single operator dataset , 2010, Prenatal diagnosis.

[16]  Ian R Smith,et al.  Use of graphical statistical process control tools to monitor and improve outcomes in cardiac surgery. , 2013, Heart, lung & circulation.

[17]  Connie M. Borror,et al.  Robustness of the EWMA Control Chart to Non-Normality , 1999 .

[18]  A. Borrell,et al.  The CUSUM test applied in prospective nuchal translucency quality review , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[19]  Michael B. C. Khoo,et al.  A STUDY OF THE MEDIAN RUN LENGTH (MRL) PERFORMANCE OF THE EWMA t CHART FOR THE MEAN , 2012 .

[20]  Michael M. Wagner,et al.  Detection of Pediatric Respiratory and Gastrointestinal Outbreaks from Free-Text Chief Complaints , 2003, AMIA.

[21]  H. Cuckle.  Monitoring quality control of nuchal translucency. , 2010, Clinics in laboratory medicine.

[22]  J. Wisser,et al.  Continuous independent quality control for fetal nuchal translucency measurements provided by the cumulative summation technique. , 2011, Ultraschall in der Medizin.

[23]  A. Dobson,et al.  The application of statistical process control charts to the detection and monitoring of hospital-acquired infections. , 2001, Journal of quality in clinical practice.

[24]  S. Larsen,et al.  Quality assessment in prospective nuchal translucency screening for Down syndrome , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[25]  N Goris,et al.  Quality assurance/quality control of foot and mouth disease solid phase competition enzyme-linked immunosorbent assay--Part II. Quality control: comparison of two charting methods to monitor assay performance. , 2005, Revue scientifique et technique.

[26]  T. Lau,et al.  Quality assurance of nuchal translucency for prenatal fetal Down syndrome screening , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[27]  John S. Oakland,et al.  Statistical Process Control , 2018 .

[28]  M. Hynek,et al.  Quality Assessment of Fetal Nuchal Translucency Measurements in the First Trimester of Pregnancy , 2011 .

[29]  K. Nicolaides.  Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. , 2004, American journal of obstetrics and gynecology.

[30]  R. Snijders,et al.  First‐trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[31]  A. Rudnicka,et al.  First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, New England Journal of Medicine.

[32]  K. Nicolaides,et al.  Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. , 1992, BMJ.

[33]  S. W. Roberts,et al.  Control Chart Tests Based on Geometric Moving Averages , 2000, Technometrics.

[34]  K. Kagan,et al.  A mixture model of nuchal translucency thickness in screening for chromosomal defects , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[35]  L. Scrucca,et al.  qcc: An R package for quality control charting and statistical process control , 2004 .

[36]  D. Krantz,et al.  Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance , 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[37]  Eric R. Ziegel,et al.  Applied Statistics and Probability for Engineers , 2002, Technometrics.

[38]  M. Coory,et al.  Exponentially weighted moving average charts to compare observed and expected values for monitoring risk-adjusted hospital indicators , 2011, Quality and Safety in Health Care.

[39]  Kristian Linnet.  The exponentially weighted moving average (EWMA) rule compared with traditionally used quality control rules , 2006, Clinical chemistry and laboratory medicine.

[40]  Chris Thomas,et al.  Risk-adjusted continuous outcome monitoring with an EWMA chart: could it have detected excess mortality among intensive care patients at Bundaberg Base Hospital? , 2010, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[41]  K. Kagan,et al.  Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21 , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[42]  A. Hackshaw,et al.  Correct estimation of parameters for ultrasound nuchal translucency screening - Authors' reply , 1998 .

[43]  M. Evans,et al.  Undermeasurement of Nuchal Translucencies: Implications for Screening , 2010, Obstetrics and gynecology.

[44]  J. Canick,et al.  Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective , 2008, Genetics in Medicine.